Researchers announced the successful removal of HIV from laboratory cells using the gene-editing technology Crispr-Cas. Dr. Elena Herrera-Carrillo and her team from Amsterdam UMC in the Netherlands oversaw the research....CONTINUE READING THE FULL ARTICLE>>>
They presented their findings at the European Congress of Clinical Microbiology and Infectious Diseases, emphasising the consequences for HIV treatment.
The study attempted to create a Crispr-Cas regimen that might target HIV DNA in infected cells. According to Dr. Herrera-Carrillo, the findings point to a possible HIV cure. She did, however, advise that more research and optimisation of delivery techniques are required before clinical trials can commence.
The researchers emphasised the importance of caution, stating that while the data are encouraging, it is too early to declare an HIV cure. They advised ongoing research and vigilance in pursuing potential therapy options.
“Only then can we consider clinical trials of ‘cure’ in humans to disable the HIV reservoir. “While these preliminary findings are very encouraging, it is premature to declare that there is a functional HIV cure on the horizon,’’ the researchers said…CONTINUE READING>>
